Kelly K Hunt (@kellykhunt) 's Twitter Profile
Kelly K Hunt

@kellykhunt

Professor of Surgery at MD Anderson Cancer Center. Devoted to cancer care & research. Tweets are my own.

ID: 2880750378

calendar_today28-10-2014 13:12:28

626 Tweet

2,2K Followers

482 Following

Kelly K Hunt (@kellykhunt) 's Twitter Profile Photo

When we identify gBRCA mutations in patients it can impact surgical decision-making and adjuvant therapy recommendations. Cascade testing can also be important for family members. #bcsm Stephanie Graff, MD, FACP, FASCO

Kelly K Hunt (@kellykhunt) 's Twitter Profile Photo

Let’s start the conversation. It takes the whole multidisciplinary team to develop the optimal treatment program for our patients Stephanie Graff, MD, FACP, FASCO Dr. Terry Mamounas Society of Surgical Oncology ASBrS #BRCAbrief #bcsm

Kelly K Hunt (@kellykhunt) 's Twitter Profile Photo

Agree Stephanie Graff, MD, FACP, FASCO and patients with germline #BRCA mutations who have residual disease following neoadjuvant systemic therapy should be considered for adjuvant therapy with a PARP inhibitor. #BRCAbrief

Kelly K Hunt (@kellykhunt) 's Twitter Profile Photo

Learn more about integrating olaparib in the management of patients with germline BRCA mutations who have early breast cancer bit.ly/40djS76

Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

Happy #InternationalDayofWomenandGirlsinScience! Today, we celebrate the incredible women shaping the future of surgical oncology through research, innovation, and leadership. SSO is proud to support and uplift women in science! #SSOCommunity

Happy #InternationalDayofWomenandGirlsinScience!  Today, we celebrate the incredible women shaping the future of surgical oncology through research, innovation, and leadership. SSO is proud to support and uplift women in science! #SSOCommunity
Kelly K Hunt (@kellykhunt) 's Twitter Profile Photo

Thanks Stephanie Graff, MD, FACP, FASCO #BRCA testing can have implications for individual patient treatment plans and potential for cascade testing to their family members. #BRCAbrief

Khandan Keyomarsi (@kandymarsy) 's Twitter Profile Photo

We are pleased to share our latest findings on the molecular mechanisms driving resistance to CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer, published in Molecular Cancer rdcu.be/d92sw (Luo et al., 2025, DOI: 10.1186/s12943-025-02226-9)!

OncoDaily (@oncodaily) 's Twitter Profile Photo

Targeting the Cell Cycle Machinery in Cancer with Khandan Keyomarsi and Kelly K Hunt - Wafik S. El-Deiry, MD, PhD, FACP oncodaily.com/blog/wafik-el-… #FightAgainstCancer #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

The Society of Surgical Oncology is pleased to announce the newly installed Officers and Board Members as they officially begin their term for the 2025-2026 governance year. Please join us in welcoming them! ow.ly/sWLx50Vsw6g

The Society of Surgical Oncology is pleased to announce the newly installed Officers and Board Members as they officially begin their term for the 2025-2026 governance year. Please join us in welcoming them! ow.ly/sWLx50Vsw6g
Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

New episode! Dr. Olga Kantor, Brigham and Women’s Hospital, and Dr. Taiwo Adesoye, MD Anderson Cancer Center, dive into key breast track highlights from #SSO2025 — including practice-changing trials you won’t want to miss. Listen now: ow.ly/c9yp50W8Bok

New episode!

Dr. Olga Kantor, Brigham and Women’s Hospital, and Dr. Taiwo Adesoye, MD Anderson Cancer Center, dive into key breast track highlights from #SSO2025 — including practice-changing trials you won’t want to miss.

Listen now: ow.ly/c9yp50W8Bok